Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22402037 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants
Condition: Nonneoplastic Condition
Interventions: Biological: PADRE-CMV fusion peptide vaccine;   Biological: tetanus-CMV fusion peptide vaccine;   Drug: agatolimod sodium

Indicates status has not been verified in more than two years